Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shane Mackey

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Transplantation Reports|May 5, 2015
Adoptive T Regulatory Cell Therapy for Tolerance InductionCecilia Cabello-Kindelan, Shane Mackey, Allison L Bayer
Diabetes|November 13, 2019
Immunomodulation Followed by Antigen-Specific T<sub>reg</sub> Infusion Controls Islet AutoimmunityCecilia Cabello-Kindelan, Shane Mackey, Alexander Sands, et al.
Nature Medicine|June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Transplantation Reports|May 5, 2015
Adoptive T Regulatory Cell Therapy for Tolerance InductionCecilia Cabello-Kindelan, Shane Mackey, Allison L Bayer
Diabetes|November 13, 2019
Immunomodulation Followed by Antigen-Specific T<sub>reg</sub> Infusion Controls Islet AutoimmunityCecilia Cabello-Kindelan, Shane Mackey, Alexander Sands, et al.
Nature Medicine|June 1, 2025
Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trialStephen J Bagley, Arati S Desai, Joseph A Fraietta, et al.
Pageof 1